CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Operating Officer sold 5,584 shares at $0.58 ($3,243)
- 4 Open-market sale Chief Executive Officer sold 30,601 shares at $0.58 ($17,773)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Executive Officer sold 59,569 shares at an average $0.58 ($34,639)
- 4 Open-market sale Chief Commercial Officer sold 12,991 shares at $0.57 ($7,467)
- 4 Open-market sale Chief Medical Officer sold 22,195 shares at an average $0.58 ($12,920)
- 4 Open-market sale Chief Patient Supply Officer sold 19,542 shares at an average $0.58 ($11,360)
- 4 Open-market sale Chief Operating Officer sold 19,542 shares at an average $0.58 ($11,360)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
Page 4 of 41 · 808 filings